Pharmaceutical Executive
May 01, 2012
Issue PDF
0
0
Marooned at the Top
May 01, 2012
From the Editor
0
0
The industry's reputation as a growth industry no one wants to pay for is more secure than ever, writes Pharm Exec Editor William Looney.
May 01, 2012
Features
0
0
Will changes to the P&R system in the UK finally put some real metrics behind the elusive concept of value?
May 01, 2012
Features
0
0
More consolidation didn't boost sales at the top, but a handful of nimble newcomers posted impressive growth on the other end of the curve.
May 01, 2012
Country Report
0
0
In just the past few years, South Africa has hit several key economic benchmarks demonstrating the country's upward trajectory.
May 01, 2012
Special Section
0
0
Companies know they need regulatory information management. What they don't always know is where to start and how to weave this vital capability across the enterprise.
May 01, 2012
Special Section
0
0
Options for using data have proliferated to the point of becoming overwhelming. So what opportunities does this information explosion present?
May 01, 2012
Column
0
0
In late March, the Supreme Court debated the merits-or lack thereof-of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?
May 01, 2012
Column
0
0
To gain market access in emerging markets, pharma companies face pressure to offer a convincing Corporate Value Proposition to governments.
May 01, 2012
Special Section
0
0
Data has become as important as the drug in driving success in healthcare.
May 01, 2012
Special Section
0
0
Highlighting the companies awarded for exemplifying a high level of operational excellence with technology.